VANCOUVER, BC, Jan. 11, 2022 /PRNewswire/ -- Clarius Mobile Health is poised to deliver on its promise to make high-definition...
Brand refresh and new website position company as a leader in digital pharma technologiesBOSTON, MA / ACCESSWIRE / January 11,...
TULSA, OK / ACCESSWIRE / January 11 , 2022 / Limitless Venture Group, Inc. (OTC PINK:LVGI) ("LVGI" or the "Company"),...
Cloud DX and partner Maxwell Telecare sign three new clinics for Remote Patient Monitoring (RPM) deployment, expanding on its Maxwell...
REDWOOD CITY, CA / ACCESSWIRE / January 11, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the...
What employers must do, can do, and should do to protect their workforce and their customers from COVID-19SAN DIEGO, CA...
FT. MYERS, FL / ACCESSWIRE / January 11, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing...
As Industry Dynamics Shift, Smaller Biotechnology Companies Will Continue to Drive Dealmaking in 2022MORRISVILLE, N.C., Jan. 11, 2022 (GLOBE NEWSWIRE) --...
Former Health Advances Partner Wyatt Gotbetter appointed Head of Parexel Worldwide Access Consulting to drive growth in consulting businessBOSTON, and...
-A greater than 50% reduction in SARS-CoV-2 Delta viral load was observed- -REVTx-99 was tested prior to infection in multiple...
LEXINGTON, Mass., Jan. 11, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing...
Company’s Intellectual Property Portfolio Expands to over 415 Filed or Issued Patents; 265 of Which are Focused on XBAR® (BAW)...
SOLANA BEACH, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) announced that the United Kingdom’s Home...
REDWOOD CITY, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated...
American Journal of Nephrology data demonstrates KidneyIntelX successfully monitors patient response to SGLT2 therapy in 1,325 CANagliflozin CardioVAScular Assessment Study...
Enrollment complete in INTERGRIS-IPF Phase 2a clinical trial with top-line data expected mid-2022 FDA has authorized evaluation of long-term treatment...
Company on track to report three-month interim study results, including visual acuity, visual sensitivity, mobility and safety data, in Q2...
Forbes Technology Council, Invitation-Only Community for World-Class Technology Executives, Welcomes Dr. Saltman of Eko Eko Chief Medical Officer Dr. Adam...
Yumanity achieves research milestone in its collaboration with Merck; Yumanity to receive $5 million milestone payment Michael J. Fox Foundation...
Dana Brown and Timothy Norris Irish offer extensive experience in technology, women’s breast health and unique global perspectivesNASHUA, N.H., Jan....